PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cell Biology of Viral Infection Lab, Instituto Gulbenkian de Ciência; Oeiras, Portugal.\', \'ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa; Oeiras, Portugal.\', \'Lymphocyte Physiology Lab, Instituto Gulbenkian de Ciência; Oeiras, Portugal.\', \'CEDOC NOVA, Centro de Estudos de Doenças Crónicas, Nova Medical School, Universidade Nova de Lisboa; Lisboa, Portugal.\', \'Genomics Unit, Instituto Gulbenkian de Ciência; Oeiras, Portugal.\', \'Bioinformatics Unit, Instituto Gulbenkian de Ciência; Oeiras, Portugal.\', \'The Wellcome Trust Sanger Institute; Hinxton, United Kingdom.\', \'Disease Genetics Lab, Instituto Gulbenkian de Ciência; Oeiras, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009772
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34352039
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34352039>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34352039>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all